The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, New Horizon Health's share price is HK$14.14.
New Horizon Health's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was HK$3.26. Hence, New Horizon Health's PS Ratio for today is 4.34.
Good Sign:
New Horizon Health Ltd stock PS Ratio (=7) is close to 5-year low of 7
The historical rank and industry rank for New Horizon Health's PS Ratio or its related term are showing as below:
HKSE:06606'
s PS Ratio Range Over the Past 10 Years
Min: 4.34 Med: 24.13 Max: 427.5
Current: 4.34
During the past 5 years, New Horizon Health's highest PS Ratio was 427.50. The lowest was 4.34. And the median was 24.13.
HKSE:06606's PS Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 3.215
vs HKSE:06606: 4.34
During the past 5 years, New Horizon Health's highest 3-Year average Revenue per Share Growth Rate was 138.10% per year. The lowest was 135.30% per year. And the median was 136.70% per year.
Back to Basics: PS Ratio
New Horizon Health PS Ratio Historical Data
The historical data trend for New Horizon Health's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of New Horizon Health's PS Ratio
For the Medical Devices subindustry, New Horizon Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
New Horizon Health's PS Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, New Horizon Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where New Horizon Health's PS Ratio falls into.
New Horizon Health PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
New Horizon Health's Share Price of today is HK$14.14.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. New Horizon Health's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was HK$3.26.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
New Horizon Health (HKSE:06606) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
New Horizon Health PS Ratio Related Terms
Thank you for viewing the detailed overview of New Horizon Health's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
New Horizon Health (HKSE:06606) Business Description
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06606 has been successfully added to your 